Raised $1.2M · Aug 11, 2026announcement ↗
Exobiosphere
BiotechLuxembourgexobiosphere.com ↗
What they do
Exobiosphere develops automated, high-throughput platforms for biomedical experiments in microgravity. The Luxembourg-based biotech serves pharmaceutical and research organizations with target identification, drug development, and disease-phenotyping services in areas including oncology, ageing, neurodegeneration, and inflammation.
Hiring outlook
With approximately $1.17 million in funding and an early-stage platform, the company may prioritize founding-level scientists and engineers in space systems, automation, biology, and data analysis. It may also add partnership or business-development support as it builds relationships with pharmaceutical, academic, and space-sector organizations.
Open roles
No open roles on their board right now.